These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 17674415

  • 1. Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial.
    Mendonça DA, Menezes K, Jog MS.
    Mov Disord; 2007 Oct 31; 22(14):2070-6. PubMed ID: 17674415
    [Abstract] [Full Text] [Related]

  • 2. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
    Bruera E, Valero V, Driver L, Shen L, Willey J, Zhang T, Palmer JL.
    J Clin Oncol; 2006 May 01; 24(13):2073-8. PubMed ID: 16648508
    [Abstract] [Full Text] [Related]

  • 3. Using modafinil to treat fatigue in Parkinson disease: a double-blind, placebo-controlled pilot study.
    Lou JS, Dimitrova DM, Park BS, Johnson SC, Eaton R, Arnold G, Nutt JG.
    Clin Neuropharmacol; 2009 May 01; 32(6):305-10. PubMed ID: 19620846
    [Abstract] [Full Text] [Related]

  • 4. Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial.
    Kerr CW, Drake J, Milch RA, Brazeau DA, Skretny JA, Brazeau GA, Donnelly JP.
    J Pain Symptom Manage; 2012 Jan 01; 43(1):68-77. PubMed ID: 22208450
    [Abstract] [Full Text] [Related]

  • 5. Does methylphenidate reduce the symptoms of chronic fatigue syndrome?
    Blockmans D, Persoons P, Van Houdenhove B, Bobbaers H.
    Am J Med; 2006 Feb 01; 119(2):167.e23-30. PubMed ID: 16443425
    [Abstract] [Full Text] [Related]

  • 6. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy.
    Butler JM, Case LD, Atkins J, Frizzell B, Sanders G, Griffin P, Lesser G, McMullen K, McQuellon R, Naughton M, Rapp S, Stieber V, Shaw EG.
    Int J Radiat Oncol Biol Phys; 2007 Dec 01; 69(5):1496-501. PubMed ID: 17869448
    [Abstract] [Full Text] [Related]

  • 7. Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial.
    Nutt JG, Carter JH, Carlson NE.
    Arch Neurol; 2007 Mar 01; 64(3):319-23. PubMed ID: 17353373
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T.
    J Clin Psychopharmacol; 2009 Jun 01; 29(3):239-47. PubMed ID: 19440077
    [Abstract] [Full Text] [Related]

  • 9. Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study.
    Rabkin JG, Gordon PH, McElhiney M, Rabkin R, Chew S, Mitsumoto H.
    Muscle Nerve; 2009 Mar 01; 39(3):297-303. PubMed ID: 19208404
    [Abstract] [Full Text] [Related]

  • 10. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report.
    Bruera E, Driver L, Barnes EA, Willey J, Shen L, Palmer JL, Escalante C.
    J Clin Oncol; 2003 Dec 01; 21(23):4439-43. PubMed ID: 14645434
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial.
    Lower EE, Fleishman S, Cooper A, Zeldis J, Faleck H, Yu Z, Manning D.
    J Pain Symptom Manage; 2009 Nov 01; 38(5):650-62. PubMed ID: 19896571
    [Abstract] [Full Text] [Related]

  • 12. Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study.
    Lou JS, Kearns G, Benice T, Oken B, Sexton G, Nutt J.
    Mov Disord; 2003 Oct 01; 18(10):1108-14. PubMed ID: 14534913
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of a 20-mg dose of methylphenidate for the treatment of daytime sleepiness in adult patients with myotonic dystrophy type 1: a 2-center, randomized, double-blind, placebo-controlled, 3-week crossover trial.
    Puymirat J, Bouchard JP, Mathieu J.
    Clin Ther; 2012 May 01; 34(5):1103-11. PubMed ID: 22578232
    [Abstract] [Full Text] [Related]

  • 14. Randomized controlled trial of modafinil for the treatment of fatigue in postpolio patients.
    Chan KM, Strohschein FJ, Rydz D, Allidina A, Shuaib A, Westbury CF.
    Muscle Nerve; 2006 Jan 01; 33(1):138-41. PubMed ID: 16175627
    [Abstract] [Full Text] [Related]

  • 15. A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.
    Medori R, Ramos-Quiroga JA, Casas M, Kooij JJ, Niemelä A, Trott GE, Lee E, Buitelaar JK.
    Biol Psychiatry; 2008 May 15; 63(10):981-9. PubMed ID: 18206857
    [Abstract] [Full Text] [Related]

  • 16. A randomized, controlled crossover trial of ondansetron in patients with primary biliary cirrhosis and fatigue.
    Theal JJ, Toosi MN, Girlan L, Heslegrave RJ, Huet PM, Burak KW, Swain M, Tomlinson GA, Heathcote EJ.
    Hepatology; 2005 Jun 15; 41(6):1305-12. PubMed ID: 15915460
    [Abstract] [Full Text] [Related]

  • 17. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.
    Clin Ther; 2007 Jun 15; 29(6):1168-77. PubMed ID: 17692731
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
    Lizogub VG, Riley DS, Heger M.
    Explore (NY); 2007 Jun 15; 3(6):573-84. PubMed ID: 18005909
    [Abstract] [Full Text] [Related]

  • 19. Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge.
    Herrmann N, Rothenburg LS, Black SE, Ryan M, Liu BA, Busto UE, Lanctôt KL.
    J Clin Psychopharmacol; 2008 Jun 15; 28(3):296-301. PubMed ID: 18480686
    [Abstract] [Full Text] [Related]

  • 20. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.
    Storch A, Jost WH, Vieregge P, Spiegel J, Greulich W, Durner J, Müller T, Kupsch A, Henningsen H, Oertel WH, Fuchs G, Kuhn W, Niklowitz P, Koch R, Herting B, Reichmann H, German Coenzyme Q(10) Study Group.
    Arch Neurol; 2007 Jul 15; 64(7):938-44. PubMed ID: 17502459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.